Xenerex Biosciences
Records under this name other than patents Xenerex Biosciences holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Xenerex Biosciences
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,537,809 | Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof Lapsed on the fee record Ended Mar 25, 2015 · USPTO record | Lapsed on the fee record | Ended Mar 25, 2015 | USPTO record |
| US 5,476,996 | Human immune system in non-human animal Term ended Term ended no later than Dec 19, 2015 · Low confidence | Term ended | Term ended no later than Dec 19, 2015 | Low confidence |
| US 5,698,767 | Human immune system in non-human animal Term ended Term ended no later than Dec 16, 2017 · Low confidence | Term ended | Term ended no later than Dec 16, 2017 | Low confidence |
| US 5,958,765 | Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof Term ended Term ended no later than Sep 28, 2019 · Low confidence | Term ended | Term ended no later than Sep 28, 2019 | Low confidence |